Free shipping on all orders over $ 500

SBI-0206965

Cat. No. M6086

All AbMole products are for research use only, cannot be used for human consumption.

SBI-0206965 Structure
Synonym:

SBI 0206965; SBI0206965

Size Price Availability Quantity
Free Sample 0.5 mg  USD 0 In stock
10mM*1mL in DMSO USD 80  USD80 In stock
1mg USD 35  USD35 In stock
2mg USD 50  USD50 In stock
5mg USD 75  USD75 In stock
10mg USD 125  USD125 In stock
25mg USD 225  USD225 In stock
50mg USD 335  USD335 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SBI-0206965 has very high selectivity, only inhibits 10 out of 456 kinases >95% when tested at 10 μM. SBI-0206965 suppressed ULK1-mediated phosphorylation events in cells, regulating autophagy and cell survival It can suppress autophagy induced by mTOR inhibition, prevent ULK1-dependent cell survival following nutrient deprivation. It greatly synergized with mechanistic target of rapamycin (mTOR) inhibitors to kill tumor cells, providing a strong rationale for their combined use in the clinic.

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines HEK-293T
Preparation method Human embryonic kidney cells (HEK-293T) were transfected with wild-type (WT) or kinase inactive (KI) Myc-tagged ULK1 and wild-type Flag-tagged Vps34 (WT Vps34). 24 hours post-transfection, cells were treated with a panel of putative ULK1 competitive inhibitors in a dose response manner (1, 10, 50 μM). Cellular lysates were isolated after 1 hour of treatment and immunoblotted with the indicated antibodies.
Concentrations 1, 10, 50 μM
Incubation time 24 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Chemical Information
Molecular Weight 489.32
Formula C21H21BrN4O5
CAS Number 1884220-36-3
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Tang F, et al. Oncol Rep. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.

[2] Egan DF, et al. Mol Cell. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates.

Related ULK Products
XST-14

XST-14 is a potent, competitive and highly selective ULK1 inhibitor with an IC50 of 26.6 nM. XST-14 induces autophagy inhibition by reducing the phosphorylation of the ULK1 downstream substrate. XST-14 has antitumor effects.

DCC-3116 

DCC-3116 is an orally active ULK1/2 inhibitor.

DCC-3116

DCC-3116 is a first-in-class, potent and selective inhibitor of ULK1/2 kinases and autophagy. ULK1/2 are kinases that receive and process input from nutrient and stress sensors to initiate autophagy.

MRT68921 

MRT68921 is a potent inhibitor of ULK1 and ULK2, with IC50 values of 2.9 nM and 1.1 nM, respectively.

SBP-7455

SBP-7455 is a dual-Specific ULK1/2 autophagy inhibitor with IC50s of 13 nM and 476 nM for ULK1 and ULK2 in ADP-Glo assay, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: SBI-0206965, SBI 0206965; SBI0206965 supplier, ULK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.